Project Grant HT94252310007
Award Date
4/1/23
Completion Date
3/31/25
Dollars Obligated
$160K
Federal Agency
Defense Health Agency
Awardee
Emory University (S352L5PJLMP8)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Atlanta, GA 30322, USA
Similar Awards
Emory University was awarded a $159,929 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund whole-genome structural variation and CpG methylation analyses through long-read sequencing from April 1, 2023 to March 31, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care through innovative medical...
The Defense Health Agency awarded Emory University a $156,500 project grant under the Military Medical Research and Development program to support research on core transcription factors in regenerative medicine and cancer. The one-year award beginning September 30, 2023 will fund investigation into medical solutions for the battlefield by transforming healthcare through innovative biomedical research. Specifically, Emory University will conduct research on core transcription factors as they...
The Defense Health Agency awarded Emory University a $305,175 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct research on a novel therapeutic target for renal medullary carcinoma. The award period runs from July 1, 2023 to June 30, 2026. As a leading research university, Emory has a strong track record of delivering scientific research and public health services under federal grants and contracts. This award supports Emory's expertise in...
Emory University will conduct research under a $1,255,611 Project Grant from the Defense Health Agency through the Military Medical Research and Development program. The three-year award beginning in April 2023 will fund research to define the molecular basis for immunogenicity of locally advanced prostate tumors resistant to androgen deprivation therapy. The CFDA 12.420 program supports basic, applied and advanced biomedical research to transform military and public health care through...
This $240,897 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, will support integrative transcriptomic and epigenomic profiling of subependymal giant cell astrocytoma at single-cell resolution. The award was made to Duke University's Office of Research Administration on August 1, 2025, with a period of performance through July 31, 2027. The Military Medical Research and Development program funds advanced biomedical...
This $626,000 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports Emory University's research on developing immune-competent 3D bioprinted organoids to study and target barriers to cellular therapy for neuroblastoma. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical solutions. The 2-year award period runs from July 15, 2025 to July...
Emory University was awarded a $586,875 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from September 1, 2023 to August 31, 2026 to elucidate and exploit SAMHD1 for breast cancer therapy. Through this funding, Emory University researchers will investigate medical solutions for breast cancer by exploring the role of the SAMHD1 protein and developing new therapeutic approaches for...
This Project Grant, awarded by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), provides $625,994 to Emory University to support research on novel cell therapy approaches for neuroblastoma. The project aims to advance the development of new treatments for this type of pediatric cancer, which is a priority area for military medical research. Emory University, a leading academic research institution, is well-positioned to conduct this work,...
Emory University was awarded a $586,875 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from September 1, 2023 to August 31, 2026 to elucidate and exploit SAMHD1 for breast cancer therapy. Through this funding, Emory University researchers will investigate medical solutions for breast cancer by exploring the role of the SAMHD1 protein and developing new therapeutic approaches for...
The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...